Five-Year Survival of Alpha-Fetoprotein–Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report

다국어 초록 (Multilingual Abstract)

Alpha-fetoprotein–producing gastric cancer is associated with poor prognosis because of frequent liver and lymph node metastasis. We present a case with synchronous liver metastasis who survived for 5 years. A 69-year-old man with upper abdominal pain was referred to our hospital. Gastrointestinal endoscopy revealed a Borrmann II-like tumor in the lower part of the stomach. Computed tomography revealed a tumor in the left lobe of the liver. Serum alpha-fetoprotein levels were markedly increased. We performed distal gastrectomy after administering oral tegafur/gimeracil/oteracil potassium and administered hepatic intra-arterial cisplatin injection. Liver metastasis showed partial response on computed tomography. Despite left hepatic lobectomy, further metastases to the liver and mediastinal lymph nodes became difficult to control. After sorafenib tosylate administration, stabilization of the disease was observed for 4 months. We conclude that hepatic intra-arterial chemotherapy and oral administration of sorafenib tosylate may potentially improve the prognosis in such cases.

참고문헌 (Reference)

1 Gao JJ, "c-Met: a potential therapeutic target for hepatocellular carcinoma" 5 : 2-11, 2011

2 Llovet JM, "SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma" 359 : 378-390, 2008

3 Kim C, "Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer" 30 : 306-315, 2012

4 Inoue M, "Long-term results of gastrectomy for alpha-fetoproteinproducing gastric cancer" 97 : 1056-1061, 2010

5 Amemiya H, "High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein" 59 : 145-151, 2000

6 Nagahama T, "Hepatic arterial injection therapy (HAI) for metastatic liver tumor from gastric cancer" 27 : 1920-1923, 2000

7 Kochi M, "FLEP chemotherapy for alpha-fetoproteinproducing gastric cancer" 66 : 445-449, 2004

8 Huan Chun, "Clinicopathological Characteristics of Alpha-Fetoprotein- Producing Gastric Cancer" 대한위암학회 11 (11): 23-30, 2011

9 Kono K, "Clinicopathologic features of gastric cancers producing alpha-fetoprotein" 19 : 359-365, 2002

10 Ishigami S, "Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer" 53 : 338-341, 2006

11 Adachi Y, "AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients" 65 : 95-101, 2003

12 Sakurai N, "A case of non-recurred long-term survival after chemotherapy for liver metastasis of AFP-producing gastric carcinoma" 38 : 418-423, 2005

13 Asami T, "A case of AFP-producing gastric cancer with multiple liver metastases responding to CPT-11 and cisplatin combination chemotherapy" 29 : 1985-1988, 2002

14 Yoshioka M, "A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy" 38 : 105-108, 2011

15 Takada J, "A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer" 36 : 2326-2329, 2009